Pierandrea Muglia
Director/Board Member at SANA AB
Pierandrea Muglia active positions
Companies | Position | Start | End |
---|---|---|---|
SANA AB | Director/Board Member | 01/01/2023 | - |
Independent Dir/Board Member | 01/01/2023 | - |
Career history of Pierandrea Muglia
Former positions of Pierandrea Muglia
Companies | Position | Start | End |
---|---|---|---|
GRIN Therapeutics, Inc. | Founder | 01/09/2021 | 01/09/2022 |
President | 01/09/2021 | 01/09/2022 | |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01/09/2012 | 01/10/2019 |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Sales & Marketing | - | - |
NTG NORDIC TRANSPORT GROUP A/S | Director/Board Member | 28/05/2010 | 28/05/2010 |
Corporate Officer/Principal | 28/05/2010 | - |
Statistics
International
Denmark | 3 |
Belgium | 3 |
United States | 2 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 4 |
Transportation | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
SANA AB | Health Technology |
Private companies | 3 |
---|---|
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Health Technology |
GRIN Therapeutics, Inc. |
- Stock Market
- Insiders
- Pierandrea Muglia
- Experience